Mira Pharmaceuticals Inc (MIRA)
0.637
-0.01
(-2.00%)
USD |
NASDAQ |
Jun 28, 16:00
0.637
0.00 (0.00%)
After-Hours: 20:00
Mira Pharmaceuticals Total Liabilities (Quarterly): 0.652M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 0.652M |
| December 31, 2023 | 0.5581M |
| September 30, 2023 | 0.9029M |
| Date | Value |
|---|---|
| June 30, 2023 | 2.628M |
| March 31, 2023 | 2.187M |
| December 31, 2022 | 1.454M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
0.5581M
Minimum
Dec 2023
2.628M
Maximum
Jun 2023
1.397M
Average
1.179M
Median
Total Liabilities (Quarterly) Benchmarks
| Merck & Co Inc | 65.42B |
| Innovative Eyewear Inc | 0.9114M |
| NovaBay Pharmaceuticals Inc | 5.197M |
| Palatin Technologies Inc | 9.827M |
| iBio Inc | 25.29M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 3.809M |
| Shareholders Equity (Quarterly) | 3.157M |